Induced sputum eicosanoid concentrations in asthma.

Induced sputum eicosanoid concentrations in asthma.

Further definition of the role of leukotrienes (LT) and prostaglandins (PG) in asthma would be helped by a noninvasive method for assessing airway production. The supernatant from sputum induced with hypertonic saline and dispersed using dithiotrietol has been successfully used to measure other mole...

Bibliográfalaš dieđut
Váldodahkkit:	Pavord, I, Ward, R, Woltmann, G, Wardlaw, A, Sheller, JR, Dworski, R
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	1999

Geahča maid

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma.
Dahkki: Brightling, C, et al.
Almmustuhtton: (2000)

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma
Dahkki: Brightling, C, et al.
Almmustuhtton: (2000)

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids.
Dahkki: Green, R, et al.
Almmustuhtton: (2002)

Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics.
Dahkki: Macfarlane, A, et al.
Almmustuhtton: (2000)

Between-observer repeatability of sputum differential cell counts. Influence of cell viability and squamous cell contamination.
Dahkki: Ward, R, et al.
Almmustuhtton: (1999)

Between observer repeatability of sputum differential cell counts. Influence of cell viability and squamous cell contamination
Dahkki: Ward, R, et al.
Almmustuhtton: (1997)

Objective quantitative analysis of eosinophils and bronchial epithelial cells in induced sputum by laser scanning cytometry.
Dahkki: Woltmann, G, et al.
Almmustuhtton: (1999)

The safety and success rate of sputum induction using a low output ultrasonic nebuliser.
Dahkki: Hunter, C, et al.
Almmustuhtton: (1999)

Induced sputum inflammatory mediator concentrations in chronic cough.
Dahkki: Birring, S, et al.
Almmustuhtton: (2004)

Non-eosinophilic corticosteroid unresponsive asthma.
Dahkki: Pavord, I, et al.
Almmustuhtton: (1999)

Eosinophils in asthma and other allergic diseases.
Dahkki: Wardlaw, A, et al.
Almmustuhtton: (2000)

Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma.
Dahkki: Brightling, C, et al.
Almmustuhtton: (1999)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
Dahkki: Green, R, et al.
Almmustuhtton: (2002)

A comparison of the validity of different diagnostic tests in adults with asthma.
Dahkki: Hunter, C, et al.
Almmustuhtton: (2002)

New insights into the relationship between airway inflammation and asthma.
Dahkki: Wardlaw, A, et al.
Almmustuhtton: (2002)

Prednisone-dependent asthma: inflammatory indices in induced sputum.
Dahkki: Pizzichini, M, et al.
Almmustuhtton: (1999)

Increased sputum and bronchial biopsy IL-13 expression in severe asthma.
Dahkki: Saha, S, et al.
Almmustuhtton: (2008)

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.
Dahkki: Berry, M, et al.
Almmustuhtton: (2004)

The influence of age on induced sputum differential cell counts in normal subjects.
Dahkki: Thomas, R, et al.
Almmustuhtton: (2004)

Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma.
Dahkki: Desai, D, et al.
Almmustuhtton: (2013)

Eicosanoid Control Over Antigen Presenting Cells in Asthma
Dahkki: Nincy Debeuf, et al.
Almmustuhtton: (2018-09-01)

Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability.
Dahkki: Brightling, C, et al.
Almmustuhtton: (2001)

Clinicians should be proactive in testing for asthma.
Dahkki: Wardlaw, A, et al.
Almmustuhtton: (1999)

Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1.
Dahkki: Agbetile, J, et al.
Almmustuhtton: (2012)

Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial.
Dahkki: Brightling, C, et al.
Almmustuhtton: (2000)

Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD.
Dahkki: Bafadhel, M, et al.
Almmustuhtton: (2009)

Measurement of Markers of Inflammation in Induced Sputum and Exhaled Air
Dahkki: Pavord, I, et al.
Almmustuhtton: (2009)

Eicosanoids in exhaled breath condensate of airway inflammation in patients with asthma
Dahkki: Yotaro Takaku, et al.
Almmustuhtton: (2016-09-01)

The use of induced sputum to investigate airway inflammation.
Dahkki: Pavord, I, et al.
Almmustuhtton: (1997)

The use of induced sputum to investigate airway inflammation
Dahkki: Pavord, I, et al.
Almmustuhtton: (1997)

Mechanisms of FeNO non-suppression in severe asthma: analysis of sputum type 2 cytokines and chemokines
Dahkki: Couillard, S, et al.
Almmustuhtton: (2020)

Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study.
Dahkki: Birring, S, et al.
Almmustuhtton: (2002)

Sputum Il-17a levels correlate with biomarkers of non-eosinophilic inflammation in patients with asthma
Dahkki: Hynes, G, et al.
Almmustuhtton: (2017)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
Dahkki: Berry, M, et al.
Almmustuhtton: (2005)

Alternatives to induced sputum for identifying inflammatory subtypes of asthma.
Dahkki: Simpson, J, et al.
Almmustuhtton: (2017)

EICOSANOIDS AND INFLAMMATION
Dahkki: A. E. Karateev, et al.
Almmustuhtton: (2016-12-01)

TNF-alpha in asthma.
Dahkki: Berry, M, et al.
Almmustuhtton: (2007)

The use of induced sputum in clinical trials.
Dahkki: Kips, J, et al.
Almmustuhtton: (2002)

Management of asthma in adults: current therapy and future directions.
Dahkki: Green, R, et al.
Almmustuhtton: (2003)

Asthma exacerbations and sputum eosinophil counts.
Dahkki: Currie, G, et al.
Almmustuhtton: (2003)